91精品国产手机在线-白筒袜嫩萝双腿之间乳白液体-青青操手机在线视频观看-日本中文字幕人妻日韩-日韩精品在线观看视频网站-天堂资源中文最新版在线一区-欧美专区一区二区三区-国产综合亚洲欧美在线-国产精品久久久久久福利69堂

專(zhuān)家論壇|尹明:HBV感染的動(dòng)物模型研究進(jìn)展( 四 )


不清楚造成HBV嚴(yán)格種屬特異性的原因 , 因而HBV動(dòng)物模型都存在各自的優(yōu)勢(shì)和不足 。 盡管如此 , 這些模型可以部分模擬HBV感染患者的特征 , 合理的選擇這些模型 , 將有助于加快藥篩進(jìn)程、驗(yàn)證新療法和更快解決HBV生物學(xué)發(fā)病機(jī)制等方面的問(wèn)題 。 由于HBV發(fā)病機(jī)制的復(fù)雜性 , 已經(jīng)有研究表明 , 宿主因素影響HBV的感染 。 如許多基因(如HLA和IL-4)的遺傳多態(tài)性會(huì)影響抗原呈遞或細(xì)胞因子的產(chǎn)生 , 從而影響抗體的產(chǎn)生 , 導(dǎo)致對(duì)疫苗接種的反應(yīng)程度不同 。 NTCP的多態(tài)性可能決定HBV進(jìn)入的過(guò)程 。 宿主因素也可能影響先天性和適應(yīng)性免疫 , 包括巨噬細(xì)胞的激活和吞噬、APCs的抗原呈遞以及HBV特異性T淋巴細(xì)胞的啟動(dòng)和功能 , 從而影響HBV的清除和持續(xù)性 。 人類(lèi)相關(guān)基因的遺傳多態(tài)性可以直接或間接地決定這些免疫功能 。 例如 , 目前的人源化NTCP轉(zhuǎn)基因或者定點(diǎn)敲入KI模型 , 只能實(shí)現(xiàn)HDV的瞬時(shí)感染 , 不能實(shí)現(xiàn)HBV的感染 。 如果 , 通過(guò)人源化導(dǎo)入HBV的受體和HBV關(guān)鍵易感基因 , 實(shí)現(xiàn)小鼠肝細(xì)胞對(duì)HBV的易感性并產(chǎn)生cccDNA , 必將促進(jìn)HBV小鼠模型臨床前模型質(zhì)的飛躍 。 相信隨著研究的進(jìn)一步突破 , 將會(huì)有更理想的HBV臨床前模型出現(xiàn) , 為最終治愈乙型肝炎提供幫助 。
參考文獻(xiàn):
[1]WANG J, HUANG YX, SHEN Y, et al. Research advances in mouse models of hepatitis B virus infection[J]. J Clin Hepatol, 2016, 32(1): 165-168. DOI: 0.3969/j.issn.1001-5256.2016.01.036.
王軍, 黃豫曉, 沈燕, 等. HBV感染小鼠模型的研究進(jìn)展[J]. 臨床肝膽病雜志, 2016, 32(1): 165-168. DOI: 0.3969/j.issn.1001-5256.2016.01.036.
[2]BLUMBERG BS, ALTER HJ, VISNICH S. A "New" antigen in leukemia sera[J]. JAMA, 1965, 191: 541-546. DOI: 10.1001/jama.1965.03080070025007. PMID: 14239025.
[3]DANE DS, CAMERON CH, BRIGGS M. Virus-like particles in serum of patients with Australia-antigen-associated hepatitis[J]. Lancet, 1970, 1(7649): 695-698. DOI: 10.1016/s0140-6736(70)90926-8. PMID: 4190997.
[4]BURWITZ BJ, ZHOU Z, LI W. Animal models for the study of human hepatitis B and D virus infection: New insights and progress[J]. Antiviral Res, 2020, 182: 104898. DOI: 10.1016/j.antiviral.2020.104898.
[5]YAN H, ZHONG G, XU G, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus[J]. Elife, 2012, 1: e00049. DOI: 10.7554/eLife.00049.
[6]LEMPP FA, MUTZ P, LIPPS C, et al. Evidence that hepatitis B virus replication in mouse cells is limited by the lack of a host cell dependency factor[J]. J Hepatol, 2016, 64(3): 556-564. DOI: 10.1016/j.jhep.2015.10.030.
[7]LEMPP FA, WIEDTKE E, QU B, et al. Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytes[J]. Hepatology, 2017, 66(3): 703-716. DOI: 10.1002/hep.29112.
[8]MENG Z, CHEN Y, LU M. Advances in targeting the innate and adaptive immune systems to cure chronic hepatitis B virus infection[J]. Front Immunol, 2019, 10: 3127. DOI: 10.3389/fimmu.2019.03127.
[9]RYBICKA M, BIELAWSKI KP. Recent advances in understanding, diagnosing, and treating hepatitis B virus infection[J]. Microorganisms, 2020, 8(9): 1416. DOI: 10.3390/microorganisms8091416.
[10]BABINET C, FARZA H, MORELLO D, et al. Specific expression of hepatitis B surface antigen (HBsAg) in transgenic mice[J]. Science, 1985, 230(4730): 1160-1163. DOI: 10.1126/science.3865370.
[11]BURK RD, DELOIA JA, ELAWADY MK, et al. Tissue preferential expression of the hepatitis B virus (HBV) surface antigen gene in two lines of HBV transgenic mice[J]. J Virol, 1988, 62(2): 649-654. DOI: 10.1128/JVI.62.2.649-654.1988.
[12]CHISARI FV, PINKERT CA, MILICH DR, et al. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state[J]. Science, 1985, 230: 1157-1160. DOI: 10.1126/science.3865369.
[13]GUIDOTTI LG, MARTINEZ V, LOH YT, et al. Hepatitis B virus nucleocapsid particles do not cross the hepatocyte nuclear membrane in transgenic mice[J]. J Virol, 1994, 68(9): 5469-5475. DOI: 10.1128/JVI.68.9.5469-5475.1994.
[14]MILICH DR, JONES JE, HUGHES JL, et al. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?[J]. Proc Natl Acad Sci U S A, 1990, 87(17): 6599-6603. DOI: 10.1073/pnas.87.17.6599.
[15]KIM CM, KOIKE K, SAITO I, et al. HBx gene of hepatitis B virus induces liver cancer in transgenic mice[J]. Nature, 1991, 351(6324): 317-320. DOI: 10.1038/351317a0.
[16]LEE TH, FINEGOLD MJ, SHEN RF, et al. Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice[J]. J Virol, 1990, 64(12): 5939-5947. DOI: 10.1128/JVI.64.12.5939-5947.1990.
[17]ARAKI K, MIYAZAKI J, HINO O, et al. Expression and replication of hepatitis B virus genome in transgenic mice[J]. Proc Natl Acad Sci U S A, 1989, 86(1): 207-211. DOI: 10.1073/pnas.86.1.207.

推薦閱讀